What is H.C. Wainwright's price target for ALDX?

H.C. Wainwright's latest stated price target for Aldeyra Therapeutics Inc. (ALDX) is $2, from its action on Mar 18, 2026.

What is H.C. Wainwright's rating on ALDX?

H.C. Wainwright rates ALDX Neutral, a neutral rating, as of Mar 18, 2026.

When did H.C. Wainwright last change its view on ALDX?

On Mar 18, 2026, H.C. Wainwright downgrades to Neutral from Buy, price target $2.

Analyst firms · H.C. Wainwright · ALDX

H.C. Wainwright ALDX price target and rating history

Aldeyra Therapeutics Inc. (ALDX) · Health Care

H.C. Wainwright rates Aldeyra Therapeutics Inc. (ALDX) Neutral with a $2 price target, as of its latest action on Mar 18, 2026. It has published 3 rating actions on ALDX since April 2022, including 0 upgrades and 1 downgrade.

Current rating: Neutral
Price target: $2
Median target, all firms: Too few
Actions on ALDX: 3

H.C. Wainwright price target on ALDX

H.C. Wainwright price target on ALDX, each point a stated target, April 2022 to March 2026.

Every H.C. Wainwright rating on ALDX

Mar 18, 2026
DowngradeH.C. Wainwright downgrades to Neutral from Buy, price target $2
Apr 2, 2024
ResumeH.C. Wainwright resumes coverage at Buy, price target $10
Apr 27, 2022
ResumeH.C. Wainwright resumes coverage at Buy, price target $15

Questions about H.C. Wainwright and ALDX

What is H.C. Wainwright's price target for ALDX?: H.C. Wainwright's latest stated price target for Aldeyra Therapeutics Inc. (ALDX) is $2, from its action on Mar 18, 2026.
What is H.C. Wainwright's rating on ALDX?: H.C. Wainwright rates ALDX Neutral, a neutral rating, as of Mar 18, 2026.
When did H.C. Wainwright last change its view on ALDX?: On Mar 18, 2026, H.C. Wainwright downgrades to Neutral from Buy, price target $2.

All H.C. Wainwright ratings ALDX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.